docetaxel anhydrous has been researched along with miltefosine in 1 studies
Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (miltefosine) | Trials (miltefosine) | Recent Studies (post-2010) (miltefosine) |
---|---|---|---|---|---|
12,110 | 3,216 | 6,920 | 1,330 | 83 | 769 |
Protein | Taxonomy | docetaxel anhydrous (IC50) | miltefosine (IC50) |
---|---|---|---|
RAC-alpha serine/threonine-protein kinase | Homo sapiens (human) | 9.6 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bhutani, KK; Gohil, VM; Jain, S; Kushwah, V; Lunagariya, NA; Neelagiri, S; Singh, S | 1 |
1 other study(ies) available for docetaxel anhydrous and miltefosine
Article | Year |
---|---|
Design, synthesis and biological evaluation of 1,3,6-trisubstituted β-carboline derivatives for cytotoxic and anti-leishmanial potential.
Topics: Antiprotozoal Agents; Apoptosis; Carbolines; Cell Line, Tumor; Cell Proliferation; Drug Design; Drug Evaluation, Preclinical; HeLa Cells; Humans; Inhibitory Concentration 50; Leishmania donovani; MCF-7 Cells; Microscopy, Confocal; Structure-Activity Relationship | 2016 |